Subsequent studies by Kis-Toth et al. (46) showed that SLE patients had a reduced number of SLAMF4+ CD8+ T cells, reduced SAP expression, and reduced cytotoxicity compared with healthy donors. Here, CD8A is linked to systemic lupus erythematosus.